Skip to content
foodoseGet my numbers
ScienceMay 28, 20263 min read

GLP-1 Stigma and Judgment: Inside the Rice Paradox

A Rice University study found GLP-1 stigma and judgment runs deeper than expected: medication users were judged more harshly than dieters, or non-losers.

A new study has put a name to something many women on a GLP-1 already feel in their bodies: the quiet sense that they should keep the medication a secret. Researchers from Rice University, the Mayo Clinic, and UCLA found a clear pattern of GLP-1 stigma and judgment. People who lost weight using a medication like Ozempic, Wegovy, Mounjaro, or Zepbound were judged more harshly than people who lost the same weight through diet and exercise. On some measures, they were judged more harshly than people who did not lose weight at all.

What happened

The study, published in the International Journal of Obesity and reported by Rice University on 4 May 2026, ran two randomised experiments with 1,313 US participants. Each person read a short description of a fictional individual and then rated them. The only thing that changed between groups was how that person had managed their weight: with a GLP-1 (the generic name is a glucagon-like peptide-1 receptor agonist, semaglutide or tirzepatide), through diet and exercise, or not at all.

Lead author Erin Standen, an assistant professor of psychological sciences at Rice, expected some bias. The size of it surprised her. "There's a narrative that using these medications is taking the easy way out," she said, "and that belief seems to shape how people are judged." The team also found that anyone who regained weight was rated more negatively, whether the loss first came from a medication or a diet.

Why this judgment is really diet culture in disguise

Read the finding plainly and the logic falls apart. Weight loss is supposed to be the goal. Yet the people who reached it with medical help were punished for the method. That is not a verdict on health. It is the old diet-culture belief that weight loss only counts if you suffered for it, dressed up in concern.

GLP-1 medications act on appetite, blood sugar, and the gut. They are tools, the way insulin and statins are tools. A woman who quiets her food noise with a prescription has not cheated. She has used medicine for a medical condition, often alongside the harder, less visible work of protecting her muscle with strength training and eating enough protein. The "easy way out" story erases all of that.

What it means for you

If you have felt you must hide your pen, this study is permission to stop carrying that weight. The judgment is real, but it is not yours to absorb. It belongs to the person making it.

A few steadying truths. Your worth was never tied to a number on the scale, and it is certainly not tied to how you reached it. The most important things you are building are the ones no one can see: preserved lean muscle, steadier energy, a calmer relationship with food. Stigma also has a cost the researchers flagged, which is that it can quietly stop people from speaking openly with their prescriber. Do not let it. Your appointments are yours, and honesty there protects you. If the shame is wearing on your mood, that is worth naming too, because GLP-1 medications and emotional health are more connected than most people expect.

What to do with this

This site does not grade anyone's day. It gives you four numbers and the arithmetic behind them, and leaves the judgement out.

Get your numbers

People also ask
Are people judged for losing weight with a GLP-1?
The research says yes, and more harshly than you might expect. Researchers from Rice University, the Mayo Clinic and UCLA, publishing in the International Journal of Obesity and reported on 4 May 2026, found that people who lost weight using a medication like Ozempic, Wegovy, Mounjaro or Zepbound were judged more harshly than people who lost the same weight through diet and exercise. On some measures they were judged more harshly than people who did not lose weight at all.
How was the GLP-1 stigma study designed?
Two randomised experiments with 1,313 US participants. Each person read a short description of a fictional individual and then rated them. The only thing that changed between groups was how that person had managed their weight: with a GLP-1, through diet and exercise, or not at all. Holding everything else constant is what isolates the judgment.
Should I tell people I am taking a GLP-1?
That is your call, and the research is useful mainly because it tells you the feeling is not imagined. If you have ever felt you should keep the medication quiet, the judgment is real, the bias belongs to the people holding it, and you owe no one an explanation.
Read the originalRice University / International Journal of ObesityOpen
Go deeper

The news changes weekly. What protects your body doesn't.

Work yours out once: your calorie target, your protein floor, and three days of food built to them. Free, and no sign-up.

More from the Brief